Maes M - Search Results

1

Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment.

Wichers MC, Kenis G, Leue C, Koek G, Robaeys G, Maes M. Wichers MC, et al. Among authors: maes m. Biol Psychiatry. 2006 Jul 1;60(1):77-9. doi: 10.1016/j.biopsych.2005.11.024. Epub 2006 Feb 17. Biol Psychiatry. 2006. PMID: 16487941 Clinical Trial.

2

Neutrophil chemotaxis, phagocytosis, and superoxide release in depressive illness.

Maes M, Stevens W, DeClerck L, Peeters D, Bridts C, Schotte C, Meltzer H, Scharpé S, Cosyns P. Maes M, et al. Biol Psychiatry. 1992 Jun 15;31(12):1220-4. doi: 10.1016/0006-3223(92)90341-v. Biol Psychiatry. 1992. PMID: 1327195

3

Evidence for an immune response in major depression: a review and hypothesis.

Maes M. Maes M. Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jan;19(1):11-38. doi: 10.1016/0278-5846(94)00101-m. Prog Neuropsychopharmacol Biol Psychiatry. 1995. PMID: 7708925 Review.

4

Cytokines in major depression.

Maes M. Maes M. Biol Psychiatry. 1994 Oct 1;36(7):498-9. doi: 10.1016/0006-3223(94)90652-1. Biol Psychiatry. 1994. PMID: 7811853 No abstract available.

5

Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression.

Maes M, Scharpé S, Meltzer HY, Cosyns P. Maes M, et al. Biol Psychiatry. 1993 Nov 15;34(10):690-701. doi: 10.1016/0006-3223(93)90042-c. Biol Psychiatry. 1993. PMID: 8292673

6

Indicators of immune activation in major depression.

Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K. Sluzewska A, et al. Among authors: maes m. Psychiatry Res. 1996 Oct 16;64(3):161-7. doi: 10.1016/s0165-1781(96)02783-7. Psychiatry Res. 1996. PMID: 8944394

7

Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: suppressive effects of glucocorticoids.

Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Van Gastel A, Bergmans R, Desnyder R. Maes M, et al. Biol Psychiatry. 1996 Dec 15;40(12):1273-81. doi: 10.1016/0006-3223(95)00627-3. Biol Psychiatry. 1996. PMID: 8959292

8

Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.

Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R. Maes M, et al. Biol Psychiatry. 1997 Sep 1;42(5):349-58. doi: 10.1016/S0006-3223(96)00365-4. Biol Psychiatry. 1997. PMID: 9276075 Clinical Trial.

9

In vivo immunomodulatory effects of clozapine in schizophrenia.

Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY. Maes M, et al. Schizophr Res. 1997 Aug 29;26(2-3):221-5. doi: 10.1016/s0920-9964(97)00057-1. Schizophr Res. 1997. PMID: 9323354

10

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Maes M, et al. Cytokine. 1997 Nov;9(11):853-8. doi: 10.1006/cyto.1997.0238. Cytokine. 1997. PMID: 9367546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,500 results

Search Page

Filters